Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2003
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
11/04/2003US6642207 Artificial chromosome constructs containing foreign nucleic acid sequences
11/04/2003US6642052 Generating genetically engineered viral particle; obtain viral genome, incubate with regulatory sequences, allow homologous recombination transfect cells, recover genetically engineered viral particle
11/04/2003US6642032 Uses of avian interferon gamma (IFN-γ)
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641819 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
11/04/2003US6641818 Cellular proteins which mediate herpesvirus entry
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641816 Use of poxviruses as enhancer of specific immunity
11/04/2003US6641814 Identification and characterization of a number of M. tuberculosis derived novel proteins and protein fragments (SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 17-23, 42, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, and others, polypeptides,
11/04/2003US6641813 Methods and reagents for diagnosis of autoantibodies
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003US6641810 Methods of using geldanamycin and FK506 to treat peripheral nerve damage
11/04/2003CA2085191C Vaccines based on modified type 1 bovine herpesviruses
11/04/2003CA2084677C Apo ai polypeptides, antibodies, and immunoassays
11/04/2003CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose
11/04/2003CA2071811C Improved meningococcal polysaccharide conjugate vaccine
10/2003
10/30/2003WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/30/2003WO2003089629A1 Rapid generation of activated mononuclear antigen presenting cells from monocytes
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089596A2 Novel prostate tumor-specific promoter
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089590A2 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
10/30/2003WO2003089584A2 Use of parapox b2l protein to modify immune responses to administered antigens
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089574A2 Synthetic glyco-lipo-peptides as vaccines
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089569A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/30/2003WO2003089462A2 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003WO2003089460A1 Immunological methods and compositions for the treatment of alzheimer's disease
10/30/2003WO2003089453A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003089046A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003WO2003089009A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/30/2003WO2003089002A1 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
10/30/2003WO2003089001A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
10/30/2003WO2003089000A2 Anti-hiv composition, production method thereof and medicament
10/30/2003WO2003088999A1 Process for producing immunogloblin preparation
10/30/2003WO2003088997A2 Reduction of unwanted immune reactions
10/30/2003WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003088994A2 Modified vaccinia virus ankara for the vaccination of neonates
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088946A1 Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088898A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003065881A3 Medical device with coating that promotes endothelial cell adherence and differentiation
10/30/2003WO2003063725A3 Methods of preventing and treating flavivirus infection in animals
10/30/2003WO2003057837A8 Methods for using anti-muc18 antibodies
10/30/2003WO2003056295A3 Enterococcal virulence factors
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003037370A3 Anthrax antigenic compositions
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024480A3 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002103362A3 Cancer associated protein
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002098370A3 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002094851A3 Peptide vaccines against group a streptococci
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002079247A3 Intimins in the prevention or treatment of infections:ii
10/30/2003WO2002074788A3 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES
10/30/2003WO2002074330A3 Mycobacterrial estracts for treating autoimmune diseases
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002064162A3 Vaccine for transcutaneous immunization
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002056909A3 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids
10/30/2003WO2002028429A9 Modulation of allergic response
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003US20030204321 Efficient algorithm for PCR testing of blood samples
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204074 Streptococcus pneumoniae 37-kDa surface adhesin a protein
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204068 Nucleotide sequences coding campylobacter proteins for use in preventing bacterial, fungal and viral infection as well as treat gastrointestinal disorders and peptic ulcers; genetic vaccines
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/30/2003US20030203869 Expression vectors for stimulating an immune response and methods of using the same
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1823